Connection

MILTON FINEGOLD to Mice, Transgenic

This is a "connection" page, showing publications MILTON FINEGOLD has written about Mice, Transgenic.
Connection Strength

0.515
  1. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res. 1996; 51:123-54; discussion 155-7.
    View in: PubMed
    Score: 0.078
  2. TFEB regulates murine liver cell fate during development and regeneration. Nat Commun. 2020 05 18; 11(1):2461.
    View in: PubMed
    Score: 0.026
  3. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Exp Mol Med. 2018 01 05; 50(1):e423.
    View in: PubMed
    Score: 0.022
  4. Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2016 06 14; 113(24):E3384-93.
    View in: PubMed
    Score: 0.020
  5. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A. 1995 Apr 11; 92(8):3439-43.
    View in: PubMed
    Score: 0.019
  6. ?-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Res. 2014 Aug 15; 74(16):4515-25.
    View in: PubMed
    Score: 0.017
  7. Aneuploidy as a mechanism for stress-induced liver adaptation. J Clin Invest. 2012 Sep; 122(9):3307-15.
    View in: PubMed
    Score: 0.015
  8. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology. 2012 May; 55(5):1518-28.
    View in: PubMed
    Score: 0.015
  9. Inactivation of CBF/NF-Y in postnatal liver causes hepatocellular degeneration, lipid deposition, and endoplasmic reticulum stress. Sci Rep. 2011; 1:136.
    View in: PubMed
    Score: 0.015
  10. Expression of SV40 T antigen under control of rabbit uteroglobin promoter in transgenic mice. Am J Physiol. 1991 Aug; 261(2 Pt 1):L70-6.
    View in: PubMed
    Score: 0.014
  11. Epigenetic changes play critical role in age-associated dysfunctions of the liver. Aging Cell. 2010 Oct; 9(5):895-910.
    View in: PubMed
    Score: 0.014
  12. Chromosomal integration of adenoviral vector DNA in vivo. J Virol. 2010 Oct; 84(19):9987-94.
    View in: PubMed
    Score: 0.013
  13. Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology. Proc Natl Acad Sci U S A. 2010 Jun 15; 107(24):11122-7.
    View in: PubMed
    Score: 0.013
  14. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A. 2010 Jan 26; 107(4):1437-42.
    View in: PubMed
    Score: 0.013
  15. Tissue-specific regulation of human alpha 1-antitrypsin gene expression in transgenic mice. DNA. 1989 Mar; 8(2):101-8.
    View in: PubMed
    Score: 0.012
  16. Ploidy reductions in murine fusion-derived hepatocytes. PLoS Genet. 2009 Feb; 5(2):e1000385.
    View in: PubMed
    Score: 0.012
  17. Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. J Clin Invest. 1988 Jul; 82(1):26-36.
    View in: PubMed
    Score: 0.012
  18. Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice. Cancer Res. 2008 Mar 01; 68(5):1601-8.
    View in: PubMed
    Score: 0.011
  19. Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein. Virology. 2006 Apr 10; 347(2):466-75.
    View in: PubMed
    Score: 0.010
  20. Long-term correction of ornithine transcarbamylase deficiency by WPRE-mediated overexpression using a helper-dependent adenovirus. Mol Ther. 2004 Sep; 10(3):492-9.
    View in: PubMed
    Score: 0.009
  21. Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest. 2004 May; 113(9):1266-70.
    View in: PubMed
    Score: 0.009
  22. Development of T-cell lymphomas in Emu-IEX-1 mice. Oncogene. 2003 Oct 09; 22(44):6845-51.
    View in: PubMed
    Score: 0.008
  23. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A. 2003 Sep 30; 100 Suppl 1:11881-8.
    View in: PubMed
    Score: 0.008
  24. Phenotypic consequences of lung-specific inducible expression of FGF-3. Proc Natl Acad Sci U S A. 2001 May 08; 98(10):5898-903.
    View in: PubMed
    Score: 0.007
  25. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol. 2001 Apr; 75(8):3851-8.
    View in: PubMed
    Score: 0.007
  26. Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells. Am J Pathol. 2001 Feb; 158(2):571-9.
    View in: PubMed
    Score: 0.007
  27. Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. J Virol. 2000 Jun; 74(11):5266-72.
    View in: PubMed
    Score: 0.007
  28. The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues. Mol Cell Biol. 2000 Jun; 20(12):4462-73.
    View in: PubMed
    Score: 0.007
  29. Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia. Oncogene. 2000 Apr 27; 19(18):2186-93.
    View in: PubMed
    Score: 0.007
  30. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev. 1999 Jan 15; 13(2):213-24.
    View in: PubMed
    Score: 0.006
  31. Investigating stem cells in the lung. Adv Pediatr. 1998; 45:363-96.
    View in: PubMed
    Score: 0.006
  32. Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res. 1997 Nov 01; 57(21):4687-91.
    View in: PubMed
    Score: 0.006
  33. Tissue-specific and developmental regulation of the rat insulin II gene enhancer, RIPE3, in transgenic mice. J Biol Chem. 1997 Feb 07; 272(6):3567-72.
    View in: PubMed
    Score: 0.005
  34. Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice. Cell Growth Differ. 1997 Feb; 8(2):145-55.
    View in: PubMed
    Score: 0.005
  35. Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis, and increased germ cell tumorigenesis. Endocrinology. 1996 Nov; 137(11):4837-43.
    View in: PubMed
    Score: 0.005
  36. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog. 1996 Apr; 15(4):261-9.
    View in: PubMed
    Score: 0.005
  37. Gi2 alpha protein deficiency: a model of inflammatory bowel disease. J Clin Immunol. 1995 Nov; 15(6 Suppl):101S-105S.
    View in: PubMed
    Score: 0.005
  38. cis-acting elements involved in the regulation of mouse Clara cell-specific 10-kDa protein gene. In vitro and in vivo analysis. J Biol Chem. 1995 Feb 10; 270(6):2689-94.
    View in: PubMed
    Score: 0.005
  39. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol. 1994 Feb; 8(2):230-9.
    View in: PubMed
    Score: 0.004
  40. Cloning and tissue-specific expression of the cDNA for the mouse Clara cell 10 kD protein: comparison of endogenous expression to rabbit uteroglobin promoter-driven transgene expression. Am J Respir Cell Mol Biol. 1993 Sep; 9(3):231-8.
    View in: PubMed
    Score: 0.004
  41. The human osteocalcin promoter directs bone-specific vitamin D-regulatable gene expression in transgenic mice. Mol Endocrinol. 1993 Mar; 7(3):462-7.
    View in: PubMed
    Score: 0.004
  42. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 1992 Nov 26; 360(6402):313-9.
    View in: PubMed
    Score: 0.004
  43. Tissue- and development-specific expression of the human phenylalanine hydroxylase/chloramphenicol acetyltransferase fusion gene in transgenic mice. J Biol Chem. 1992 Jul 25; 267(21):15105-10.
    View in: PubMed
    Score: 0.004
  44. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A. 1991 Feb 15; 88(4):1217-21.
    View in: PubMed
    Score: 0.003
  45. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol. 1990 Dec; 64(12):5939-47.
    View in: PubMed
    Score: 0.003
  46. SV40 large T antigen directed by regulatory elements of the human alpha-1-antitrypsin gene. A transgenic mouse system that exhibits stages in liver carcinogenesis. Intervirology. 1990; 31(2-4):85-100.
    View in: PubMed
    Score: 0.003
  47. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene. Cancer Res. 1989 Nov 01; 49(21):6108-17.
    View in: PubMed
    Score: 0.003
  48. Elevated synthesis of human alpha 1-antitrypsin hinders the secretion of murine alpha 1-antitrypsin from hepatocytes of transgenic mice. J Biol Chem. 1989 Sep 15; 264(26):15696-700.
    View in: PubMed
    Score: 0.003
  49. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest. 1989 Apr; 83(4):1183-90.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.